SCHEMBL24923482

SCHEMBL24923482

c1cc(-c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc(-n2c3ccccc3c3ccc4c5ccccc5sc4c32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ALOX5 P09917 1/20 0.37
MAPT P10636 5/20 0.36
RXFP1 Q9HBX9 1/20 0.36
TP53 P04637 4/20 0.34
HDAC4 P56524 1/20 0.33
TNKS O95271 1/20 0.32
TNKS2 Q9H2K2 1/20 0.32
PRKDC P78527 1/20 0.31
HSD17B10 Q99714 1/20 0.31
LIMK1 P53667 2/20 0.30
KMT2A Q03164 1/20 0.30
IL1R1 P14778 1/20 0.30
GPR3 P46089 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675461 1.00 KDM4E (0.40) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL24676206 1.00 KDM4E (0.40) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL24675464 0.99 ALOX5 (0.38) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL19653645 0.96 L3MBTL1 (0.39) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL23862203 0.96 L3MBTL1 (0.39) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL24676369 0.95 KDM4E (0.40) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL23862256 0.94 L3MBTL1 (0.40) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL19652896 0.94 L3MBTL1 (0.40) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL10014565 0.94 ATM (0.39) KDM4EATML3MBTL1ALOX5MAPT
SCHEMBL24676255 0.94 MAPT (0.39) KDM4EATML3MBTL1ALOX5MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230033529-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE LEF1, L1CAM, RAP1A KDM4E 3096/4885ATM 2806/4885L3MBTL1 173/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.